The purpose of this review is to summarize the results of reports of injectable agents for the treatment of female urinary stress @entity322 . Five agents were reviewed: collagen, Teflon, autologous fat, @entity1346 microparticles, and @entity1346 microballoons. Collagen was the most frequently reported agent and yielded short-term cure and improved rates of 74%-100%. This deteriorated to approximately 57% with longer term follow-up. Teflon has similarly lower longer term than short-term success rates, at 33%-76%. The reported local complications and the potential for particle migration have resulted in its lack of widespread acceptance. Autologous fat has yielded the lowest success rate. Longer term success in a small number of @entity1346 microparticle articles was similar to the other injectables at approximately 60%. Early success with @entity1346 microballoons was 70%. The technique is generally free of major morbidity. The indication for injectables is @entity1690 but @entity8018 is not a contraindication. Long-term durability, cost effectiveness, and some safety issues still have to be addressed by further clinical trials.

Current status of injectable agents for female stress urinary XXXX .

@entity1690 :: ('MESH:D046628', 'Disease') :: ['intrinsic sphincter deficiency'] @entity1346 :: ('MESH:D012828', 'Chemical') :: ['silicone'] @entity322 :: ('MESH:D014549', 'Disease') :: ['incontinence'] @entity8018 :: ('MESH:C536196', 'Disease') :: ['hypermobility']
@entity322 :: (MESH:D014549,Disease) :: ['incontinence']
